039860 — NanoenTek Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for NanoenTek, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	26,256	29,443	35,784	35,201	26,837
Cost of Revenue
Gross Profit	12,707	14,339	17,690	16,911	12,342
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	24,044	26,577	31,746	30,820	29,066
Operating Profit	2,212	2,866	4,038	4,381	-2,229
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,276	2,115	5,470	5,508	-1,205
Provision for Income Taxes
Net Income After Taxes	5,750	2,737	7,321	4,665	-3,678
Net Income Before Extraordinary Items
Net Income	5,750	2,737	7,321	4,665	-3,678
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,750	2,737	7,321	4,665	-3,678
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	239	115	303	174	-137
Dividends per Share